Company profile · Sponsor
Tempest
Tempest Therapeutics
- Pipeline
- 3
- Drugs
- 0
- Patents
- 8
Quick answer
Tempest (TPST) is a pharma company. headquartered in BRISBANE, CA, USA. listed on NYSE. NovaPharmaNews links 3 pipeline programs, 0 drugs, and 8 patents to this profile..
Company facts
Pipeline (3)
Search pipeline →Patents (8)
Search patents →-
US 12215093
Bicyclic carboxamides and methods of use thereof
granted -
US 11795156
Bicyclic carboxamides and methods of use thereof
granted -
US 11738009
Bicyclic compounds and their use in the treatment of cancer
granted -
US 11666557
Triazolone compounds and uses thereof
granted -
US 11638704
Bicyclic compounds and their use in the treatment of cancer
granted -
US 11472789
Bicyclic carboxamides and methods of use thereof
granted -
US 11066405
Bicyclic compounds and their use in the treatment of cancer
granted -
US 10968201
Bicyclic carboxamides and methods of use thereof
granted
Frequently asked questions
What is Tempest?
Tempest (TPST) is a pharma company. headquartered in BRISBANE, CA, USA. listed on NYSE. NovaPharmaNews links 3 pipeline programs, 0 drugs, and 8 patents to this profile..
What pipeline programs does Tempest sponsor?
We track 3 ClinicalTrials.gov-linked programs for Tempest, including TPST-1120 and 2 more. Open each program for phase, modality, NCT IDs, and indication details.
Where does Tempest company data come from?
Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.